ArticleESMO real world data and digital oncology2024

Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data.

M J Emmett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.